104 related articles for article (PubMed ID: 2894000)
1. Polymorphism of the human c-abl gene: relation to incidence and course of chronic myelogenous leukemia.
Daniel L; Ahmed CM; Bloodgood RS; Kidd JR; Castiglione CM; Duttagupta S; Lebowitz P
Oncogene; 1987 May; 1(2):193-200. PubMed ID: 2894000
[TBL] [Abstract][Full Text] [Related]
2. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
[TBL] [Abstract][Full Text] [Related]
3. [Amplification and rearrangement of proto-oncogene c-abl in human leukemia cells].
Jin XM; Miao J; Xu Y; Deng GR
Zhonghua Zhong Liu Za Zhi; 1988 May; 10(3):167-70. PubMed ID: 3219975
[TBL] [Abstract][Full Text] [Related]
4. Novel restriction fragment length polymorphisms in the cellular oncogene SEA.
Koduru PR; Goh JC; Broome JD
Hematol Pathol; 1992; 6(2):71-8. PubMed ID: 1351480
[TBL] [Abstract][Full Text] [Related]
5. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
Okabe M
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
[TBL] [Abstract][Full Text] [Related]
6. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
[TBL] [Abstract][Full Text] [Related]
7. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity in expression of the bcr-abl fusion transcript in CML blast crisis.
Andrews DF; Collins SJ
Leukemia; 1987 Oct; 1(10):718-24. PubMed ID: 3312834
[TBL] [Abstract][Full Text] [Related]
9. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
10. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
[TBL] [Abstract][Full Text] [Related]
11. Coding sequence and intron-exon junctions of the c-myb gene are intact in the chronic phase and blast crisis stages of chronic myeloid leukemia patients.
Bussolari R; Candini O; Colomer D; Corradini F; Guerzoni C; Mariani SA; Cattelani S; Silvestri C; Pecorari L; Iacobucci I; Soverini S; Fasano T; Martinelli G; Cervantes F; Calabretta B
Leuk Res; 2007 Feb; 31(2):163-7. PubMed ID: 16797705
[TBL] [Abstract][Full Text] [Related]
12. The bcr gene is joined to c-abl in Ph1 chromosome negative chronic myelogenous leukemia.
Dreazen O; Klisak I; Rassool F; Goldman JM; Sparkes RS; Gale RP
Oncogene Res; 1988; 2(2):167-75. PubMed ID: 3217110
[TBL] [Abstract][Full Text] [Related]
13. Detailed mapping of methylcytosine positions at the CpG island surrounding the Pa promoter at the bcr-abl locus in CML patients and in two cell lines, K562 and BV173.
Fajkusová L; Fajkus J; Polácková K; Fulnecek J; Dvoráková D; Krahulcová E
Blood Cells Mol Dis; 2000 Jun; 26(3):193-204. PubMed ID: 10950939
[TBL] [Abstract][Full Text] [Related]
14. Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia.
Watzinger F; Gaiger A; Karlic H; Becher R; Pillwein K; Lion T
Cancer Res; 1994 Jul; 54(14):3934-8. PubMed ID: 8033117
[TBL] [Abstract][Full Text] [Related]
15. Further evidence of the involvement of the c-abl oncogene in chronic myelogenous leukemia and acute lymphocytic leukemia.
Szabo P; Macera MJ; Verma RS
Mol Biol Med; 1988 Dec; 5(3):139-44. PubMed ID: 3072467
[TBL] [Abstract][Full Text] [Related]
16. Chronic myelogenous leukemia: amplification of a rearranged c-abl oncogene in both chronic phase and blast crisis.
Collins SJ; Groudine MT
Blood; 1987 Mar; 69(3):893-8. PubMed ID: 3545323
[TBL] [Abstract][Full Text] [Related]
17. Breakpoints on chromosomes 9 and 22 in Philadelphia chromosome-positive chronic myelogenous leukemia (CML). Amplification of rearranged c-abl oncogenes in CML blast crisis.
Collins SJ
J Clin Invest; 1986 Nov; 78(5):1392-6. PubMed ID: 3021820
[TBL] [Abstract][Full Text] [Related]
18. [Atypical chronic myeloid leukemia with polymorphism of the BCR gene].
Hernández A; Corral L; Muñiz A; Aláez C; Martínez G
Sangre (Barc); 1991 Dec; 36(6):497-9. PubMed ID: 1687492
[TBL] [Abstract][Full Text] [Related]
19. Identification of molecular variants of p210bcr-abl in chronic myelogenous leukemia.
Kurzrock R; Kloetzer WS; Talpaz M; Blick M; Walters R; Arlinghaus RB; Gutterman JU
Blood; 1987 Jul; 70(1):233-6. PubMed ID: 2885048
[TBL] [Abstract][Full Text] [Related]
20. Molecular characteristics of chronic myelogenous leukemia in blast crisis.
Blick M; Romero P; Talpaz M; Kurzrock R; Shtalrid M; Andersson B; Trujillo J; Beran M; Gutterman J
Cancer Genet Cytogenet; 1987 Aug; 27(2):349-56. PubMed ID: 3474057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]